Market capitalization is the total value the stock market puts on a company: its share price multiplied by the number of shares outstanding. Each point here is the share count reported in a filing multiplied by the closing price on that filing date, adjusted for later stock splits, so the history moves when a new filing arrives rather than with each day's trading. A larger market cap means investors collectively value the company more highly; by itself it says nothing about profit or debt. Annual points keep the latest observation in each calendar year.
Kalaris Therapeutics, Inc. market cap for the quarter ending 2026-08-04 was $103.55M, a 113.78% increase year-over-year.
Kalaris Therapeutics, Inc. market cap for the quarter ending 2026-06-30 was $97.01M, a 97.22% increase year-over-year.
Kalaris Therapeutics, Inc. market cap for the quarter ending 2026-05-05 was $126.22M.
Kalaris Therapeutics, Inc. market cap for the quarter ending 2026-03-31 was $133.59M.
Kalaris Therapeutics, Inc. market cap for fiscal 2026 was $103.55M.
Kalaris Therapeutics, Inc. market cap for fiscal 2025 was $192.15M.